NCT04948463 2025-12-24
ELSA-FN
Murdoch Childrens Research Institute
Phase 4 Completed
Clinical Trials
95 trialsNCT04952766 2025-12-23
EREVA
Centre Hospitalier Régional d'Orléans
Phase 4 Completed
NCT06218823 2025-10-27
Tobacco Treatment Comparison for Cancer Care
University of Wisconsin, Madison
Phase 4 Completed
NCT02422745 2025-09-24
COSMOS
Brigham and Women's Hospital
Phase 4 Completed
NCT00646945 2025-09-16
Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology
Air Liquide Santé International
Phase 4 Completed
NCT04724460 2025-03-11
ONCO PE
Kyoto University, Graduate School of Medicine
Phase 4 Completed
NCT01943409 2025-02-03
Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils
University Health Network, Toronto
Phase 4 Completed
NCT05688384 2024-11-12
PACSPI-2
Region Jönköping County
Phase 4 Completed
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT01641172 2024-04-19
TASTY
University Medical Center Groningen
Phase 4 Completed
NCT00942968 2024-04-18
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Pfizer
Phase 4 Completed
NCT03895502 2023-10-04
ONCO DVT
Kyoto University, Graduate School of Medicine
Phase 4 Completed
NCT03469271 2023-09-26
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
Mayo Clinic
Phase 4 Completed
NCT04854018 2023-08-14
Indo-cyanine Green (ICG) in Paediatric Oncology MIS
Birmingham Women's and Children's NHS Foundation Trust
Phase 4 Completed
NCT04072068 2023-05-30
EDOI
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 4 Completed
NCT03145012 2023-02-08
Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Nova Scotia Health Authority
Phase 4 Completed
NCT05660694 2022-12-21
Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis
Altamash Institute of Dental Medicine
Phase 4 Completed
NCT03333655 2022-08-12
Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy
Hoffmann-La Roche
Phase 4 Completed
NCT04197089 2022-08-03
VitDURO
Germans Trias i Pujol Hospital
Phase 4 Completed
NCT04074460 2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4 Completed
NCT04479579 2022-04-22
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
McMaster University
Phase 4 Completed
NCT00153868 2021-09-23
A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer
Dartmouth-Hitchcock Medical Center
Phase 4 Completed
NCT01789281 2021-06-11
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Novartis
Phase 4 Completed
NCT01990534 2021-04-09
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Takeda
Phase 4 Completed
NCT01739764 2021-01-07
An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Hoffmann-La Roche
Phase 4 Completed
NCT04699760 2021-01-07
The Effects of n-3 LCPUFAs in Patients With Colorectal Cancer
University of Copenhagen
Phase 4 Completed
NCT03176849 2020-11-17
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Phoenix Children's Hospital
Phase 4 Completed
NCT01588184 2020-11-05
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
Hoffmann-La Roche
Phase 4 Completed
NCT03397914 2020-09-16
Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
National Cancer Institute, Egypt
Phase 4 Completed
NCT03482583 2020-05-22
Tobacco Use Treatment in Cancer Patients
University of Florida
Phase 4 Completed
NCT02815319 2020-04-28
REaCT-dex
Ottawa Hospital Research Institute
Phase 4 Completed
NCT03176121 2020-03-18
STOP Pain
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Completed
NCT03176199 2020-03-18
A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Completed
NCT03513757 2020-02-21
Dexmedetomidine and Propofol for Pediatric MRI Sedation
Medical College of Wisconsin
Phase 4 Completed
NCT02081469 2020-02-05
Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy
Chang Gung Memorial Hospital
Phase 4 Completed
NCT04187755 2019-12-06
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Indonesia University
Phase 4 Completed
NCT01201811 2019-12-05
Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
Celgene
Phase 4 Completed
NCT01525550 2019-07-30
A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
Pfizer
Phase 4 Completed
NCT01743560 2019-07-18
4EVERUK
Novartis
Phase 4 Completed
NCT02314871 2019-03-13
Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery
The Institute of Molecular and Translational Medicine, Czech Republic
Phase 4 Completed
NCT01636947 2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4 Completed
NCT00352885 2018-09-14
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
Emory University
Phase 4 Completed
NCT02581176 2018-06-26
CAP
University Hospital, Akershus
Phase 4 Completed
NCT02532634 2018-05-11
RAPA
Kangdong Sacred Heart Hospital
Phase 4 Completed
NCT03384511 2018-02-20
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
Shandong Cancer Hospital and Institute
Phase 4 Completed
NCT00882089 2018-01-25
Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients
Cancer Center of Irvine
Phase 4 Completed
NCT00882596 2018-01-25
Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients
Cancer Center of Irvine
Phase 4 Completed
NCT02641938 2018-01-02
Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury
Gangnam Severance Hospital
Phase 4 Completed
NCT01313780 2017-12-22
TOP
Mundipharma Korea Ltd
Phase 4 Completed
NCT00198276 2017-10-03
Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
Inovio Pharmaceuticals
Phase 4 Completed